Article
Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line.
Cancer research - 15 May 1995
Mirski S E, Cole S P
Abstract excerpt
Many clinically important antineoplastic agents exert their cytotoxicity through interaction with the M(r) 170,000 topoisomerase II alpha, an essential nuclear enzyme. Resistance to these agents has been associated frequently with either a decrease in the levels of topoisomerase II alpha or a qualitative change that alters the interaction of this enzyme with a drug or DNA. Using a VP-16-selected lung cancer cell...
Topics
- Base Sequence
- Blotting, Northern
- Carcinoma, Small Cell
- Cytoplasm
- DNA Topoisomerases, Type II
- Drug Resistance
- Humans
- Isoenzymes
- Lung Neoplasms
- Molecular Sequence Data
- Molecular Weight
